---
title: "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025"
ocid: "ocds-h6vhtk-04f704"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04f704"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04f704.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04f704.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "NHS ENGLAND"
published: "2025-03-21"
---

# NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

Buyer: NHS ENGLAND  
Current stage: Planning  
OCID: ocds-h6vhtk-04f704

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04f704)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04f704.json)

## Summary

NHS England has initiated the procurement planning process for the "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025". This tender is within the pharmaceutical industry category and is intended to procure Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines. The procurement process is currently in planning and entails a virtual 1:1 preliminary market engagement meeting scheduled to conclude by 11 April 2025. Interested suppliers are encouraged to register their interest and participate in the discussions regarding timelines, product details, and tender structure. The overall process and future notices are set to continue from June 2025, with the contract period specified from 1 December 2025 to 31 May 2027, with potential for renewal until 31 May 2029. The medical supplies are valued at approximately £1.5 billion and will serve NHS England's medical retinal vascular needs at locations across the United Kingdom.

This tender creates robust opportunities for businesses, particularly SMEs, involved in the pharmaceuticals sector focused on retinal treatments and drugs. The framework agreement will cover a range of treatments for serious eye conditions such as neovascular age-related macular degeneration, diabetic macular oedema, and retinopathy of prematurity. Companies specialising in pharmaceuticals, especially those producing or supplying anti-VEGF and intravitreal corticosteroid medications, are well-positioned to benefit. Engaging in this tender can lead to significant business growth and long-term collaboration with NHS England, supporting advancements in ocular health and patient care across the UK.

## Notice

Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; * neovascular (wet) age-related macular degeneration (AMD) * visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) * proliferative diabetic retinopathy (PDR) * visual impairment due to diabetic macular oedema (DME) * visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy * vision impairment associated with chronic diabetic macular oedema, (DME) * visual impairment due to myopic choroidal neovascularisation (myopic CNV) * retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease * inflammation of the posterior segment of the eye presenting as non-infectious uveitis * prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye

### Planning Information

NHS England is pleased to invite suppliers to a virtual 1:1 preliminary market engagement meeting in relation to the upcoming re-tender of the Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines Framework. The purpose of the sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, clinical aspects and KPI's. Please contact b.kullootee@nhs.net or michelle.clarke6@nhs.net to register your interest. There will also be a 7 day window for queries to be raised in writing after all sessions have concluded.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/010540-2025 |
| Notice type | UK2 - Preliminary Market Engagement Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | SME |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 21 Mar 2025 |
| Submission deadline | Not specified |
| Future notice date | 2 Jun 2025 |
| Award date | Not specified |
| Contract period | 1 Dec 2025 - 31 May 2027 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £1,516,353,164 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planning |
| Lots status | Planning |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LONDON |
| Post town | South East London |
| Postcode | SE1 8UG |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products
- 33690000 - Various medicinal products

## Release History

- 21 Mar 2025 at 08:10 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/010540-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/010540-2025
  21st March 2025 - Preliminary market engagement notice on Find a Tender

## Notice URLs

- https://www.england.nhs.uk/
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04f704. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04f704.json.